J&J COURT CASE FOR CONFIDE OWNERSHIP ARGUES THAT ARBITRATOR'S AWARD IS EXCESSIVE; ARBITRATION DECISION GIVES HOME HIV TEST ASSETS TO MILLENSON
This article was originally published in The Gray Sheet
Johnson & Johnson's Direct Access Diagnostics business should take "extraordinary precautions" to preserve the assets of its Confide home HIV testing service until litigation over ownership of the assets is resolved, attorneys for former DAD President and CEO Elliot Millenson say in a July 26 letter to J&J.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.